Please assess the completion status of the following clinical trial:

Trial Title: Vaccine Therapy in Treating Patients Who Have Received First-Line Therapy for Hodgkin's Lymphoma

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1/PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
DISEASE CHARACTERISTICS:~* Diagnosis of classic Hodgkin's lymphoma~* Must have completed first-line therapy without evidence of disease progression~PATIENT CHARACTERISTICS:~* HIV negative~PRIOR CONCURRENT THERAPY:~* See Disease Characteristics~* No more than 6 months since prior chemotherapy or radiotherapy

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 120 Years
- Healthy Volunteers: f

Study Arms:
- Cell vaccine after initial therapy for Hodgkin lymphoma (Type: EXPERIMENTAL): Hodgkin's antigens-GM-CSF-expressing cell vaccine after initial therapy.

Based on this trial design, predict the completion outcome and termination type (if applicable).